[94] As of 2002, there were 25 reports of autopsies on infants known to have FAS
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
published Phase I safety data in healthy volunteers were reported in conference proceedings, while completed Phase II efficacy results have not appeared in peer-reviewed literature
Recent animal- and human-based studies described the enhanced percentage of eryptotic erythrocytes in patients with hepatic failure and hyperbilirubinemia [210, 250, 280, 283, 284]
Benefits: Removes dead skin cells, improves skin tone and texture
Evaluation of the skin irritation using a DNA microarray on a reconstructed human epidermal model